Related Experiment Video

Updated: Jun 13, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

[Interstitial lung disease associated with surfactant protein B and C deficiencies]

Aleksandra Szczawińska-Popłonyk1, Anna Breborowicz, Renata Langfort

  • 1Klinika Pneumonologii, Alergologii Dzieciecej i Immunologii Klinicznej III Katedry Pediatrii Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu. ola@malwa.com.pl

Pneumonologia I Alergologia Polska
|May 13, 2010
PubMed

Insights

Interstitial lung disease in children stems from various factors, with surfactant protein B and C deficiencies playing a key role. These deficiencies involve genetic defects affecting protein synthesis and transport, impacting lung development and function.

Area of Science:

  • Pediatric Pulmonology
  • Genetic Medicine
  • Biochemistry

Background:

  • Interstitial lung disease (ILD) in children is complex, involving infectious, immunological, and metabolic causes.
  • Surfactant protein B (SP-B) and surfactant protein C (SP-C) deficiencies are significant contributors to pediatric ILD.
  • SP-C deficiency can arise from impaired synthesis, defective ABCA3 transporter production, or metabolic pathway abnormalities.

Purpose of the Study:

  • To discuss the clinical manifestations of ILD in children with SP-B and SP-C defects.
  • To review the radiological findings associated with these specific surfactant protein deficiencies.
  • To elucidate the molecular basis and prognosis of ILD linked to SP-B and SP-C abnormalities.

Main Methods:

  • Literature review of clinical cases and genetic studies concerning SP-B and SP-C deficiencies in pediatric ILD.
  • Analysis of reported clinical presentations and diagnostic imaging.
  • Examination of genetic mutations and their impact on surfactant protein synthesis and function.

Main Results:

  • SP-B and SP-C deficiencies present with diverse clinical symptoms and radiological patterns in children.
  • Molecular background involves defects in surfactant protein synthesis, ABCA3 transporter function, and related metabolic pathways.
  • Prognosis varies depending on the specific genetic defect and its effect on lung function.

Conclusions:

  • SP-B and SP-C deficiencies are critical genetic causes of pediatric interstitial lung disease.
  • Understanding the molecular etiology is crucial for diagnosis and management.
  • Further research into genotype-phenotype correlations can improve prognostic accuracy.

More Related Videos

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

Published on: April 7, 2021

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...